Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Director/PDMR Shareholding

11 Feb 2010 09:00

RNS Number : 0084H
Oxford Catalysts Group PLC
11 February 2010
 



11th February 2010

 

OXFORD CATALYSTS GROUP PLC

 ("Oxford Catalysts" or "the Group")

 

Director Share Dealings

 

Susan Robertson, Chief Financial Officer, has today exercised 121,361 share options under the Group's Share Option Schemes. The options' exercise price per ordinary share of the Group ("Ordinary Share") was £0.01.

 

Following this exercise, Susan Robertson holds 304,874 Ordinary Shares (representing 0.48% of the enlarged issued Ordinary Shares) and options over 404,998 Ordinary Shares (representing approximately 0.64% of the enlarged issued Ordinary Shares).

 

Roy Lipski, Chief Executive, has today exercised 1,512,425 share options under the Group's Share Option Schemes. Of the options exercised, 1,404,370 had an exercise price of £0.0489 per Ordinary Share and 108,055 had an exercise price of £0.01 per Ordinary Share.

 

Following this exercise, Roy Lipski holds 2,269,564 Ordinary Shares (representing 3.60% of the enlarged issued Ordinary Shares) and options over 942,000 Ordinary Shares (representing approximately 1.50% of the enlarged issued Ordinary Shares).

 

No shares in Oxford Catalysts Group PLC are being disposed of by either Susan Robertson or Roy Lipski.

 

The total number of Ordinary Shares in issue following the exercise of these options is 62,978,732.

 

- Ends -

 

For further information, please contact:

 

Roy Lipski, CEO, Oxford Catalysts

01235 841 700

Jonathan Marren/Oliver Stratton, KBC Peel Hunt (Nomad & Broker)

020 7418 8900

Billy Clegg/Alex Beagley, Financial Dynamics

020 7831 3113

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGIGDDUUBBGGB
Date   Source Headline
14th Mar 20237:00 amRNSAppointment of Financial Adviser
13th Mar 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:40 pmRNSSecond Price Monitoring Extn
31st Jan 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSBusiness Update
25th Jan 202311:07 amRNSVelocys and Bechtel Agreement
6th Jan 20233:06 pmRNSBlock listing Interim Review
12th Dec 20227:01 amRNS£2.5m UK Government grant for new e-fuels project
12th Dec 20227:00 amRNS£27m UK Government grant for Altalto project
27th Oct 20227:00 amRNSVelocys Reference Project Improved Decarbonisation
21st Sep 20227:00 amRNSInterim Results
8th Sep 20227:00 amRNSVelocys to participate in Barclays CEO Conference
1st Sep 20227:00 amRNSTotal Voting Rights
15th Aug 20227:00 amRNSUpdate on climate legislation
28th Jul 20227:00 amRNSAdditional Application for Block Admission
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSBlock listing Interim Review
1st Jul 20227:00 amRNSTotal Voting Rights
23rd Jun 20227:00 amRNSGrant of Share Option to Director
21st Jun 20223:01 pmRNSResults of Annual General Meeting
9th Jun 20227:00 amRNSAppointment of Chief Financial Officer
30th May 20227:00 amRNSMailing of 2021 annual report and AGM notice
23rd May 20224:31 pmRNSHolding(s) in Company
18th May 20224:35 pmRNSPrice Monitoring Extension
17th May 20227:00 amRNSFinal Results
13th May 20229:36 amRNSInvestor Presentation
29th Apr 20227:00 amRNSNotice of Results
19th Apr 20227:00 amRNSFurther business update
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:36 pmRNSPrice Monitoring Extension
4th Apr 20227:00 amRNSBusiness Update and Notice of Results
1st Apr 20223:26 pmRNSNotification of Major Holdings
1st Apr 20223:21 pmRNSNotification of Major Holdings
24th Mar 20227:00 amRNSSale and purchase option agreed for Altalto site
8th Mar 20224:40 pmRNSSecond Price Monitoring Extn
8th Mar 20224:35 pmRNSPrice Monitoring Extension
1st Mar 20221:08 pmRNSHolding(s) in Company
1st Mar 20221:04 pmRNSHolding(s) in Company
1st Mar 202212:25 pmRNSTotal Voting Rights
10th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSDirector/PDMR Shareholding
5th Jan 20224:30 pmRNSBlock listing Interim Review
23rd Dec 20217:00 amRNSHolding(s) in Company
22nd Dec 20217:00 amRNSHolding(s) in Company
20th Dec 202110:51 amRNSHolding(s) in Company
17th Dec 20218:02 amRNSExercise of Option over Altalto Project Site
17th Dec 20218:01 amRNSDirector/PDMR Dealings
15th Dec 202111:36 amRNSResults of General Meeting and Open Offer
26th Nov 20217:00 amRNSResult of Placing
25th Nov 20215:09 pmRNSProposed Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.